• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biohaven Ltd (NY: BHVN )

    49.97 -0.07 (-0.15%)
    Streaming Delayed Price Updated: 9:51 AM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Biohaven Ltd

    Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
    Biohaven, a clinical-stage biopharmaceutical company, is attracting investors with promising results for its experimental drug. 
    Via MarketBeat
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/8
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/4
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 1/5
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Sets New 52-Week High in Monday Session
    Via Investor Brand Network
    Biohaven Ltd. (NYSE: BHVN) Records 52-Week High Thursday Morning
    Via Investor Brand Network
    NYSE:BHVN Investor Alert: Investigation Concerning Possible Securities Laws Violations by Biohaven Ltd.
    San Diego, CA -- (SBWIRE) -- 08/23/2023 -- Biohaven Ltd. is under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Analysts Holding As Pfizer Waits On Two Phase 3 Studies
    Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value. 
    Via MarketBeat
    Topics Bankruptcy
    Exposures Financial Legal
    Pfizer Completes Acquisition of Biohaven Pharmaceuticals
    From Pfizer Inc.
    Via Business Wire
    Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Rise Above Previous 52-Week High
    Via Investor Brand Network
    Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Exceed 52-Week High
    Via Investor Brand Network
    Watch for Continued Gains in Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
    Via Investor Brand Network
    Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio?
    Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes,... 
    Via MarketBeat
    Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial
    From Global Coalition for Adaptive Research
    Via Business Wire
    BIOHAVEN INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Biohaven Pharmaceutical Holding Company Ltd. - BHVN
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BHVN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Biohaven Pharmaceutical Holding Company Ltd. Is Fair to Shareholders
    From Halper Sadeh LLP
    Via Business Wire
    Pfizer to Acquire Biohaven Pharmaceuticals
    From Pfizer Inc.
    Via Business Wire
    Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
    From Pfizer Inc.
    Via Business Wire
    2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
    Via AB Newswire
    Photo of Biohaven Pharmaceuticals Ringing the Opening Bell Available on Business Wire's Website and the Associated Press Photo Network
    From Biohaven Pharmaceuticals
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.